All Stories

  1. Crisis as Catalyst: The future of the NIH driving scientific discovery
  2. Understanding the cervicovaginal immune response to Lactobacillus crispatus CTV-05
  3. Veteran Mental Health Emergency Care Utilization Following SARS‐CoV‐2 Infection
  4. Epidemiology, Immunology and Clinical Characteristics of COVID-19 (EPIC3)—Database of a prospective longitudinal observational study within the Veterans Health Administration
  5. Reply to Yu et al
  6. Peripheral blood cytokine profiles predict the severity of SARS-CoV-2 infection: an EPIC3 study analysis
  7. Performance of Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis in children using cerebrospinal fluid
  8. BCG induced innate immune response heterogeneity and susceptibility to pediatric tuberculosis
  9. Diminished Mycobacterium tuberculosis–specific T-cell Responses During Pregnancy in Women With HIV and Receiving Isoniazid Preventive Therapy
  10. Bacterial Vaginosis Is Associated With Transcriptomic Changes but Not Higher Concentrations of Cervical Leukocytes in a Study of Women at High Risk for Human Immunodeficiency Virus Acquisition
  11. 1990-LB: Associations of SARS-CoV-2 Infection with Incident Diabetes among U.S. Veterans in a Longitudinal Observational Cohort
  12. Regional variation in financial hardship among US veterans during the COVID-19 pandemic
  13. Risk of Potentially Preventable Hospitalizations After SARS-CoV-2 Infection
  14. TOLLIP inhibits lipid accumulation and the integrated stress response in alveolar macrophages to control Mycobacterium tuberculosis infection
  15. Self-Reported Everyday Functioning After COVID-19 Infection
  16. Changes in Outpatient Health Care Use After COVID-19 Infection Among Veterans
  17. Vaginal Microbiota Linked to HIV Acquisition Risk Are Not Associated with Changes in Concentrations of Cervical Dendritic Cells and CD4+ T Cells
  18. Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine development
  19. Late Mortality After COVID-19 Infection Among US Veterans vs Risk-Matched Comparators
  20. Early Outcomes of SARS-CoV-2 Infection in a Multisite Prospective Cohort of Inpatient Veterans
  21. MUC5AC Genetic Variation Is Associated With Tuberculous Meningitis Cerebral Spinal Fluid Cytokine Responses and Mortality
  22. Complexity and Challenges of the Clinical Diagnosis and Management of Long COVID
  23. T-cell deficiency and hyperinflammatory monocyte responses associate with Mycobacterium avium complex lung disease
  24. TOLLIP Optimizes Dendritic Cell Maturation to Lipopolysaccharide and Mycobacterium tuberculosis
  25. A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV
  26. Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
  27. Peripheral blood T-cell deficiency and hyperinflammatory monocyte responses associate with MAC lung disease
  28. REL and BHLHE40 Variants Are Associated with IL-12 and IL-10 Responses and Tuberculosis Risk
  29. Mycobacterium tuberculosis-Specific T-Cell Responses Are Impaired During Late Pregnancy With Elevated Biomarkers of Tuberculosis Risk Postpartum
  30. Age differences in the association of comorbid burden with adverse outcomes in SARS-CoV-2
  31. Mycobacterium tuberculosis-specific T cell responses are impaired during late pregnancy with elevated biomarkers of tuberculosis risk postpartum
  32. Cirrhosis and Severe Acute Respiratory Syndrome Coronavirus 2 Infection in US Veterans: Risk of Infection, Hospitalization, Ventilation, and Mortality
  33. Trends Over Time in the Risk of Adverse Outcomes Among Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
  34. BMI and Outcomes of SARS‐CoV‐2 Among US Veterans
  35. Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection
  36. CNBP, REL, and BHLHE40 variants are associated with IL-12 and IL-10 responses and tuberculosis risk
  37. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
  38. Risk Factors for Testing Positive for Severe Acute Respiratory Syndrome Coronavirus 2 in a National United States Healthcare System
  39. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection
  40. TOLLIP resolves lipid-induced EIF2 signaling in alveolar macrophages for durable Mycobacterium tuberculosis protection
  41. Correction: Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria
  42. Bovine Tuberculosis: A Re-emerging Zoonotic Infection
  43. TOLLIP deficiency is associated with increased resistance to Legionella pneumophila pneumonia
  44. Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis
  45. Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria
  46. Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis
  47. Washington state satellite HIV clinic program: a model for delivering highly effective decentralized care in under-resourced communities
  48. The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires’ disease in humans
  49. Tuberculous meningitis
  50. A common genetic variant in the TOLLIP gene is associated with BCG vaccine responses in infants.
  51. Species-Specific Risk Factors, Treatment Decisions and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State
  52. Human ULK1 Variation and Susceptibility toMycobacterium tuberculosisInfection
  53. GeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last
  54. Genetic Variation in Toll-Interacting Protein Is Associated With Leprosy Susceptibility and Cutaneous Expression of Interleukin 1 Receptor Antagonist
  55. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics
  56. Human TOLLIP Regulates TLR2 and TLR4 Signaling and Its Polymorphisms Are Associated with Susceptibility to Tuberculosis
  57. Changes in the amplitude and timing of the hemodynamic response associated with prepulse inhibition of acoustic startle
  58. Prime-Boost Vaccination with HIV-1 Gag Protein and Cytosine Phosphate Guanosine Oligodeoxynucleotide, Followed by Adenovirus, Induces Sustained and Robust Humoral and Cellular Immune Responses
  59. Dendritic Cells Are Responsible for the Capacity of CpG Oligodeoxynucleotides to Act as an Adjuvant for Protective Vaccine Immunity Against Leishmania major in Mice
  60. Vaccination with Heat-killed Leishmania Antigen or Recombinant Leishmanial Protein and CpG Oligodeoxynucleotides Induces Long-Term Memory CD4+and CD8+T Cell Responses and Protection Against Leishmania major Infection
  61. Apolipoprotein E and apolipoprotein E receptors modulate Aβ-induced glial neuroinflammatory responses
  62. Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures
  63. Unique Lipoproteins Secreted by Primary Astrocytes From Wild Type, apoE (−/−), and Human apoE Transgenic Mice